All Articles

Market research shows doctors are eager to prescribe Moleculin's new AML drug, Annamycin. It offers hope where there is none, but can the company survive to deliver it?

As Florida celebrates National Homeownership Month, the dream of owning a home clashes with a perfect storm of insurance crises and affordability challenges.

A new firm offers up to $250k in funded accounts for prediction market traders, a move that could professionalize a booming sector. But can it navigate the complex regulatory field?

A new lawsuit alleges a Dallas nightclub's negligent security policy allowed a patron to bypass checks for a fee, leading to a security guard's murder.

Duke Energy's $500K in grants aids first responders, but it also reveals a growing reliance on private funds as public disaster support systems face strain.

With 460,000 providers enrolled, Careviso is tackling healthcare's most hated process. A case study shows it's cutting case times by more than half.

ALLSWIFIT's new Stedi Collection challenges the 'soft is best' mantra, betting that true all-day comfort comes from biomechanical support, not just cushioning.

As titans clash for the World Cup betting market, The Sports Geek unveils a new playbook focusing on data, niche audiences, and the staggering cost of fandom.

With AI veteran Andres Angelani at the helm and the launch of its HelixAI platform, 3Pillar makes a bold move to redefine enterprise transformation.

The upcoming Juneteenth closure is more than a day off. It's a window into the Postal Service's high-stakes balancing act between national duty and survival.

VFF's balance sheet didn't need the cash, so why take it? A deep dive into a strategic capital raise that's less about liquidity and more about legitimacy.

As summer plans ramp up, a new wave of AI-powered scams is set to cost consumers billions. We break down the business of fraud and how to stay protected.

How a Shark Tank alum is leveraging authentic heritage and a savvy distribution deal to redefine the multi-billion dollar American condiment market.

The federal government rolls out a dual strategy: immediate cash for households via a new grocery benefit and long-term investment to fuel Alberta's economy.

Amid a regional healthcare crisis, 475 nurses at BMC South plan to picket, citing unsafe staffing and a 'bullying' contract offer from management.

BioCardia’s innovative cell therapy for heart failure receives a crucial FDA signal, potentially paving the way for a new treatment paradigm for millions.

A new partnership aims to revolutionize battery safety by sniffing out fires before they start. But can this defense-grade tech scale for our battery-powered world?

A new drug promises the brain-rewiring benefits of psychedelics without the trip. Can Clearmind Medicine's CMND-100 transform addiction treatment?

The arrival of Riyadh Air's first Boeing 787s is more than a delivery; it's a multi-billion dollar bet on reshaping global aviation and a kingdom's future.

Kia's selection of 13 youth for the FIFA World Cup is a PR win, but a deeper look reveals a calculated strategy to embed its brand into the fabric of Canadian soccer.